Compare BFC & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BFC | GPCR |
|---|---|---|
| Founded | 1894 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | N/A | 2023 |
| Metric | BFC | GPCR |
|---|---|---|
| Price | $128.24 | $68.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $142.00 | $97.90 |
| AVG Volume (30 Days) | 62.3K | ★ 2.4M |
| Earning Date | 01-20-2026 | 11-06-2025 |
| Dividend Yield | ★ 1.42% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 7.11 | N/A |
| Revenue | ★ $168,778,000.00 | N/A |
| Revenue This Year | $11.79 | N/A |
| Revenue Next Year | $32.03 | N/A |
| P/E Ratio | $17.85 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $92.49 | $13.22 |
| 52 Week High | $139.71 | $94.90 |
| Indicator | BFC | GPCR |
|---|---|---|
| Relative Strength Index (RSI) | 42.78 | 68.61 |
| Support Level | $132.74 | $61.87 |
| Resistance Level | $137.56 | $72.00 |
| Average True Range (ATR) | 3.18 | 7.83 |
| MACD | -0.88 | 0.38 |
| Stochastic Oscillator | 1.53 | 48.10 |
Bank First Corp is a United States-based company engaged in providing financial services provides a full range of consumer and commercial financial institution services to individuals and businesses including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.